Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10927135.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sixty-one consecutive patients with locally advanced inoperable non-small-cell lung cancer were treated with chemoradiation with 60 Gy and concomitant daily low-dose cisplatin (6 mg/m(2)) in a single uninterrupted course. Toxicity was mild, 80% of patients were treated as outpatients. The median survival of 70 weeks compares favorably to the literature.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Cisplatin
- Lung Neoplasms
- Radiation-Sensitizing Agents
- Radiotherapy, Computer-Assisted